Handelsbanken Fonder Ab Castle Biosciences Inc Transaction History

Handelsbanken Fonder Ab

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$33.17 - $46.98 $265,360 - $375,840	-8,000 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$39.06 - $67.58 $7,812 - $13,516	-200 Reduced 2.44%	8,000 $343,000
Q3 2021 Nov 10, 2021	BUY	$60.13 - $77.6 $90,195 - $116,399	1,500 Added 22.39%	8,200 $545,000
Q2 2021 Aug 03, 2021	BUY	$50.07 - $76.78 $335,469 - $514,426	6,700 New	6,700 $491,000

162

25.3M

82.2K

150K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $559M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

Stay updated on Handelsbanken Fonder Ab with notifications on news.